| |
Loss for 'Rebuilding' Parent of Researcher TVG
US pharma marketing and sales group PDI has reported lower overall net revenue in Q1 2008 and an operating loss of $1.7m. Its Marketing Services division, which includes research consultancy TVG, performed better with a small increase in net revenue, but still reported an operating loss.
PDI currently operates in two business segments: Sales Services and Marketing Services. Marketing services includes TVG and medical communications agency Pharmakon.
PDI has been winding down a number of significant contracts for its Sales Services segment, and CEO Michael Marquard says the firm is 'successfully rebuilding', as well as investing significantly in development of a new service, Product Commercialization. For the latter, PDI will take financial responsibility for marketing 'products with growth potential that are mature, under-promoted and/or soon to launch into mature markets'.
Web site: www.pdi-inc.com .
|
